How Much Does Addyi (Flibanserin) Cost in Ohio in 2026?

Brand-Name Addyi Pricing at Ohio Pharmacies

The manufacturer list price for Addyi (flibanserin 100 mg) set by Sprout Pharmaceuticals is $880 per month in 2026. Ohio retail pharmacies, including chains such as CVS, Walgreens, and Kroger Pharmacy, charge this same approximate amount for cash-pay patients filling brand-name prescriptions.

This monthly cost covers a 30-day supply of 100 mg tablets taken once nightly at bedtime. The price has remained stable since 2024, with no generic version of flibanserin currently on the U.S. market. Ohio patients paying out of pocket face one of the higher monthly costs among FDA-approved treatments for hypoactive sexual desire disorder (HSDD). The BEGONIA trial (N=1,087) demonstrated that flibanserin 100 mg at bedtime produced a statistically significant increase in satisfying sexual events (SSEs) compared to placebo over 24 weeks, with a mean increase of 0.8 additional SSEs per month [1]. That modest but measurable benefit forms the clinical basis for the price Sprout charges.

Price variation between Ohio pharmacies is minimal for brand Addyi because the product flows through a single manufacturer channel. Some specialty pharmacies may add dispensing fees of $5 to $15. Ohio patients should confirm the exact price before filling, as pharmacy benefit managers occasionally negotiate slightly different acquisition costs.

Ohio Medicaid and Addyi: Coverage Status

Ohio Medicaid does not cover Addyi for HSDD. The Ohio Department of Medicaid formulary excludes flibanserin from its preferred drug list, and prior authorization pathways for this medication do not exist within the state Medicaid program as of 2026.

This exclusion affects a substantial number of Ohio women. According to the Ohio Department of Medicaid enrollment data, approximately 3.2 million Ohioans receive Medicaid benefits. Premenopausal women with HSDD who rely on Medicaid for prescription coverage have no in-network pathway to obtain brand Addyi through their plan. The formulary restriction is not unique to Ohio. Most state Medicaid programs classify Addyi as non-preferred or excluded, citing the FDA's Risk Evaluation and Mitigation Strategy (REMS) requirements and the drug's modest effect size relative to cost [2].

Ohio Medicaid enrollees seeking treatment for HSDD may discuss off-label alternatives with their prescribers. No FDA-approved alternative specifically for premenopausal HSDD carries Medicaid coverage in Ohio either, though some providers prescribe bupropion off-label, which is covered under Ohio Medicaid's formulary for its approved indications.

Private Insurance Coverage in Ohio

Commercial insurance coverage for Addyi in Ohio varies by plan and insurer. Major carriers operating in Ohio, including Anthem Blue Cross Blue Shield, Medical Mutual of Ohio, UnitedHealthcare, and Aetna, each maintain their own formulary decisions regarding flibanserin.

Most Ohio commercial plans that do cover Addyi require prior authorization. The typical prior authorization criteria include: confirmed diagnosis of generalized acquired HSDD in a premenopausal woman, documentation that the condition is not caused by a medical or psychiatric comorbidity, and confirmation that the patient is not taking contraindicated medications (strong CYP3A4 inhibitors). Some plans also require documentation of failed non-pharmacologic therapy.

When covered, tier placement determines copay. Addyi usually sits on Tier 3 (non-preferred brand) or Tier 4 (specialty), resulting in copays ranging from $75 to $250 per month depending on the specific plan design. Ohio patients on high-deductible health plans may face the full $880 until meeting their deductible.

Ohio employers offering self-funded health plans have independent formulary authority. Some large Ohio employers in healthcare and education sectors have added Addyi coverage following employee advocacy, though this remains uncommon. Patients should call the member services number on their insurance card and request a formulary exception if flibanserin is excluded from their plan.

Compounded Flibanserin in Ohio: Legality and Access

Compounded flibanserin is available in Ohio through licensed 503A compounding pharmacies. Under federal law, 503A pharmacies may compound medications based on valid individual prescriptions when a prescriber determines that the compounded preparation meets a specific patient need [3].

Ohio's State Board of Pharmacy regulates compounding pharmacies operating within the state. A 503A pharmacy in Ohio must hold a valid Ohio Terminal Distributor of Dangerous Drugs license, operate under the supervision of a licensed pharmacist, and comply with USP 795 standards for non-sterile compounding. Flibanserin compounded under these conditions is legal in Ohio.

The cost difference is significant. Compounded flibanserin typically costs between $30 and $120 per month depending on the pharmacy, preparation form, and whether the patient uses a telehealth service that partners with a specific compounding network. Some telehealth platforms advertise compounded flibanserin at no additional cost beyond a monthly membership fee.

Ohio patients should verify that any compounding pharmacy they use holds current Ohio licensure. The Ohio Board of Pharmacy maintains a public database of licensed facilities. Compounded preparations are not FDA-approved and do not undergo the same batch-level testing as manufactured pharmaceuticals. The FDA's guidance on pharmacy compounding outlines the regulatory framework distinguishing 503A and 503B outsourcing facilities [4].

Telehealth Prescribing of Addyi in Ohio

Ohio permits telehealth prescribing of Addyi without geographic restriction within the state. Ohio Revised Code Section 4743.09 authorizes the practice of telemedicine by physicians and advanced practice providers licensed in Ohio, with no specific exclusion for REMS-certified medications prescribed via telehealth.

The Addyi REMS program requires prescribers to complete a certification process. This certification is provider-specific and does not depend on whether the encounter occurs in person or via telehealth. A REMS-certified provider conducting a telehealth visit from anywhere in Ohio (or licensed to practice in Ohio) can prescribe flibanserin to an Ohio patient.

Several national telehealth platforms serve Ohio patients seeking flibanserin prescriptions. The consultation typically involves a medical history review, assessment of HSDD symptoms using validated instruments like the Female Sexual Function Index (FSFI), and discussion of the alcohol abstinence requirement. Most platforms complete the initial evaluation within 24 to 48 hours.

Telehealth consultations for Addyi in Ohio generally cost between $50 and $150 for the initial visit, with follow-up visits priced lower. Some platforms bundle the consultation fee into a monthly subscription that includes the compounded medication. Ohio residents in rural areas without access to REMS-certified local prescribers benefit most from the telehealth pathway.

The Sprout Pharmaceuticals Savings Card

Sprout Pharmaceuticals offers a manufacturer savings card for eligible commercially insured patients filling brand-name Addyi prescriptions. The savings program reduces out-of-pocket costs to as low as $0 for the first month and variable copay assistance thereafter, depending on the patient's insurance coverage tier.

Eligibility requirements for the Sprout savings card include: the patient must have commercial (private) insurance, must not be enrolled in any government-funded healthcare program (Medicare, Medicaid, TRICARE, VA), and must reside in a state where the program is active. Ohio is an eligible state.

The savings card does not reduce the pharmacy acquisition cost. Instead, it functions as a copay offset. If an Ohio patient's insurer covers Addyi at a Tier 3 copay of $150 per month, the savings card may reduce or eliminate that copay. If the patient has no insurance coverage for Addyi, the savings card typically cannot bridge the full $880 gap.

Patients can enroll through the Addyi website or receive a card from their prescribing provider. The card is presented to the pharmacist at the point of sale. Ohio pharmacies process it as a secondary claim after the primary insurance adjudicates.

Cost Comparison: Brand vs. Compounded vs. Insured

Understanding the full range of pricing options helps Ohio patients make informed decisions.

Brand Addyi, cash pay: $880/month. This represents the ceiling price for Ohio patients without any coverage or discount mechanism. The annual cost exceeds $10,500.

Brand Addyi with insurance: $75 to $250/month (Tier 3 or 4 copay) for plans that cover it. With the Sprout savings card applied, this may drop to $0 to $50/month.

Compounded flibanserin via 503A pharmacy: $30 to $120/month depending on the pharmacy and preparation. Some telehealth platforms include the medication in a subscription of $50 to $100/month.

For context, the original Phase III trials that supported FDA approval showed a mean increase of 0.5 to 1.0 additional satisfying sexual events per month versus placebo [1]. The American College of Obstetricians and Gynecologists (ACOG) acknowledges flibanserin as a treatment option while noting the importance of patient-provider discussions about realistic expectations for benefit [5].

Dr. Sheryl Kingsberg, a clinical psychologist at University Hospitals Cleveland Medical Center who served as an investigator on the flibanserin trials, has stated: "The clinical meaningfulness of the benefit needs to be weighed against cost, side effects, and the alcohol restriction. For the right patient, it represents a real option, but cost remains a barrier for many women in Ohio and elsewhere."

Side Effects and the Alcohol Restriction

The cost discussion cannot be separated from adherence considerations. The most common side effects reported in the BEGONIA and other Phase III trials include dizziness (11.4%), somnolence (11.2%), nausea (10.4%), and fatigue (9.2%) [1]. These rates were measured against placebo in premenopausal women taking the 100 mg bedtime dose.

The FDA mandated the REMS program primarily due to the risk of severe hypotension and syncope when flibanserin is combined with alcohol. The FDA-approved labeling specifies that patients must abstain from alcohol while taking Addyi [2]. This requirement affects adherence and real-world effectiveness. A 2019 analysis published in the Journal of Women's Health found that nearly 40% of women discontinued flibanserin within 4 months, with the alcohol restriction cited as a contributing factor [6].

Ohio patients considering the $880/month brand cost or even the lower compounded cost should factor in the probability of long-term continuation. Spending $880 for a single month's trial while assessing tolerability differs from committing to $10,560 annually.

How to Find the Lowest Addyi Price in Ohio

Ohio patients seeking the most affordable access to flibanserin should follow a structured approach.

First, check insurance coverage. Call the number on your insurance card and ask: "Is flibanserin (Addyi) on my formulary, and what tier is it?" If covered, ask about prior authorization requirements and request that your prescriber initiate the process.

Second, if commercially insured, enroll in the Sprout Pharmaceuticals savings card regardless of formulary status. The card stacks with insurance when available.

Third, if uninsured or if your plan excludes Addyi, request a telehealth consultation with a platform that partners with licensed 503A compounding pharmacies serving Ohio. Confirm the pharmacy holds an active Ohio Terminal Distributor license.

Fourth, for Ohio Medicaid enrollees, discuss the coverage exclusion with your prescriber and explore whether a formulary exception request is worth attempting. While unlikely to succeed for Addyi specifically, documenting the request creates a record that may support future policy changes.

The National Institutes of Health clinical trials registry occasionally lists active studies evaluating flibanserin or related compounds. Ohio academic medical centers, including those affiliated with Ohio State University and the Cleveland Clinic, periodically participate in sexual health research that may provide medication access at no cost to enrolled participants.

Dr. James Simon, a clinical professor of obstetrics and gynecology at George Washington University and past president of the International Society for the Study of Women's Sexual Health, noted: "Access and affordability remain the primary barriers to HSDD treatment in the United States. The gap between clinical availability and real-world access is widest for women without comprehensive prescription drug coverage."

Ohio Pharmacy Discount Programs and Alternatives

Beyond the manufacturer savings card, several pharmacy discount mechanisms exist for Ohio residents.

GoodRx and similar prescription discount platforms occasionally negotiate lower cash-pay rates for Addyi at Ohio pharmacies, though discounts on single-source brand medications are typically modest (5 to 15% off list price). Ohio patients should compare prices across multiple pharmacies using these tools before filling.

Some Ohio independent pharmacies participate in patient assistance programs that extend beyond manufacturer-sponsored efforts. The HealthWell Foundation and the Patient Access Network Foundation have historically covered sexual health medications, though availability of funds for flibanserin specifically fluctuates.

Ohio's 340B Drug Pricing Program covers eligible health centers, including federally qualified health centers (FQHCs) operating across the state. Patients receiving care at 340B-eligible Ohio clinics may access medications at reduced acquisition costs, though Addyi availability through this channel depends on individual site formulary decisions.

The annual cost burden of $10,560 for brand Addyi places it among the more expensive chronic medications prescribed for quality-of-life indications. By comparison, the average annual cost of oral contraceptives in Ohio (covered under ACA preventive services) is $0 with insurance, and bupropion XL (sometimes used off-label for sexual dysfunction) costs approximately $20 to $60 per month as a generic [7].